Avansdose Pharmatech Private Limited

Avansdose Pharmatech Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2017PTC115497 Incorporated 27 February 2017 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹12.71 Cr
▼ 26% YoY
Net loss · FY 2025
₹49.36 Lakh
Net margin -3.9%
EBITDA · FY 2025
-₹43.48 Lakh
EBITDA margin -3.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Avansdose Pharmatech Private Limited

Data last updated:

Avansdose Pharmatech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC115497. Its GSTIN is 37AAPCA2300R1ZC (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Ravindra Balwani and Gagan Jot Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Plot No.68 Krishna Sarada Residency Water Tank K P H B Phase 9 Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2025, the company reported a revenue of ₹12.71 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹49.36 Lakh (net margin -3.9%) and EBITDA of -₹43.48 Lakh (EBITDA margin -3.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 186% over five years.

The company is associated with 1 brand: Avansdose. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.

Avansdose Pharmatech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0084478). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avansdose.com.

Company details

CIN U74999TG2017PTC115497
Registration Number 115497
Incorporation Date 27 February 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0084478

Recognitions & Rankings of Avansdose Pharmatech

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-02-0084478

Contact details

Avansdose Pharmatech Private Limited's registered office is in Hyderabad, Telangana. Its website is avansdose.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1st Floor Plot No.68 Krishna Sarada Residency Water Tank K P H B Phase 9 Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Avansdose Pharmatech Private Limited, buy the company report.

Comprehensive company report
Avansdose Pharmatech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Avansdose Pharmatech operates one associated brand: Avansdose. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and supplies oncology APIs with R&D and quality control standards.avansdose.com

Business activity

The main business activity of Avansdose Pharmatech is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Avansdose Pharmatech Private Limited, buy the company report.

Financials of Avansdose Pharmatech Private Limited

FY 2025 filings available

Avansdose Pharmatech Private Limited reported revenue of ₹12.71 Cr (down 26% YoY) for FY 2025.

Revenue · FY 2025
₹12.71 Cr ▼ 26%
Net loss · FY 2025
₹49.36 Lakh margin -3.9%
EBITDA · FY 2025
-₹43.48 Lakh margin -3.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▲ 6%
5 years · compounded
▲ 186%
EBITDA CAGR growth
1 year
▼ 332%
3 years · compounded
▼ 74%
5 years · compounded
▼ 329%

Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 186%. EBITDA fell 332% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹43.48 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹49.36 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-3.4%
Net Profit Margin-3.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avansdose Pharmatech Private Limited, buy the company report.

Board of directors of Avansdose Pharmatech Private Limited

Avansdose Pharmatech has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ravindra BalwaniDirector27 Feb 20179 Years 8 MonthsCurrent
Gagan Jot SinghDirector27 Feb 20179 Years 8 MonthsCurrent

Peer comparison

Avansdose Pharmatech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tetrahedron Laboratories Private Limited₹12.74 Cr (FY 2018)36.0%Thane, Maharashtra, India
Telpha Samarth Private Limited₹12.71 Cr (FY 2025)65.0%New Delhi, Delhi, India
Avansdose Pharmatech Private Limitedthis company₹12.71 Cr (FY 2025)-₹49.36 Lakh-3.9%-26.0%Hyderabad, Telangana, India
Renauxe Pharma India Private Limited₹12.66 Cr (FY 2023)23.0%Ernakulam, Kerala, India
Vitara Cure Private Limited₹12.66 Cr (FY 2025)3.0%Mumbai, Maharashtra, India
Bansal Pharmachem Pvt. Ltd.₹12.62 Cr (FY 2024)4.0%New Delhi, Delhi, India
Paradigm Medivision Private Limited₹12.61 Cr (FY 2019)-21.0%Hyderabad, Telangana, India

To see the full peer comparison of Avansdose Pharmatech Private Limited, buy the company report.

Auditor

Avansdose Pharmatech Private Limited is audited by PBJ and Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PBJ and AssociatesFY 2023017752S

Shareholding

The shareholding of Avansdose Pharmatech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Avansdose Pharmatech Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Avansdose Pharmatech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Avansdose Pharmatech has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
37AAPCA2300R1ZCAndhra PradeshActive01 Feb 2020

To see the full GST registrations and return filing status of Avansdose Pharmatech Private Limited, buy the company report.

Recent activity

Avansdose Pharmatech Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Gagan Jot Singh was appointed as Director on 27 Feb 2017.

AGM
Avansdose Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Avansdose Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Gagan Jot Singh was appointed as Director.
Appointed
Ravindra Balwani was appointed as Director.
Incorporation
27 Feb 2017
Avansdose Pharmatech Private Limited was registered on 27 Feb 2017 with Roc Hyderabad & aged 9 years 8 months as per MCA records.

Frequently asked questions

Avansdose Pharmatech is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2017 (9+ years old) and is registered under CIN U74999TG2017PTC115497.

Avansdose Pharmatech has 2 current directors:

The latest financial statements of Avansdose Pharmatech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Avansdose Pharmatech is 37AAPCA2300R1ZC, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Avansdose Pharmatech is U74999TG2017PTC115497. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avansdose Pharmatech has 2 court cases on record: 2 filed by the company. 2 are pending.

Avansdose Pharmatech was incorporated on 27 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Avansdose Pharmatech by revenue are Tetrahedron Laboratories Private Limited, Telpha Samarth Private Limited, Renauxe Pharma India Private Limited, Vitara Cure Private Limited, Bansal Pharmachem Pvt. Ltd. and 1 more, all in the Pharma industry (API Manufacturers, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Gagan Jot Singh was appointed as Director on 27 Feb 2017. Ravindra Balwani was appointed as Director on 27 Feb 2017.

Yes, Avansdose Pharmatech is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0084478).

Avansdose Pharmatech can be reached through the website avansdose.com. Its registered office is in Hyderabad, Telangana, India.